United States Vasopressin Market Report & Forecast 2021-2027

Publisher Name :
Date: 29-Sep-2021
No. of pages: 93
Inquire Before Buying

United States Vasopressin Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

United States Vasopressin Market Segment Percentages, By Type, 2020 (%)

- Terlipressin

- Desmopressin

- Others

United States Vasopressin Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

United States Vasopressin Market Segment Percentages, By Application, 2020 (%)

- Hospitals

- Pharmaceutical Manufacturing

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vasopressin revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Vasopressin revenues share in United States market, 2020 (%)

Key companies Vasopressin sales in United States market, 2016-2021 (Estimated), (K Units)

Key companies Vasopressin sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Endo International

- Ferring Pharmaceuticals Corporation Information

- Fresenius Kabi

- Hybio Pharmaceutical

- Hainan Zhonghe Pharmaceutical

- Cumberland Pharmaceuticals

United States Vasopressin Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Vasopressin Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Vasopressin Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Vasopressin Overall Market Size
2.1 United States Vasopressin Market Size: 2021 VS 2027
2.2 United States Vasopressin Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Vasopressin Sales: 2016-2027
3 Company Landscape
3.1 Top Vasopressin Players in United States Market
3.2 Top United States Vasopressin Companies Ranked by Revenue
3.3 United States Vasopressin Revenue by Companies
3.4 United States Vasopressin Sales by Companies
3.5 United States Vasopressin Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Vasopressin Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Vasopressin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vasopressin Players in United States Market
3.8.1 List of Tier 1 Vasopressin Companies in United States
3.8.2 List of Tier 2 and Tier 3 Vasopressin Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Vasopressin Market Size Markets, 2021 & 2027
4.1.2 Terlipressin
4.1.3 Desmopressin
4.1.4 Others
4.2 By Type - United States Vasopressin Revenue & Forecasts
4.2.1 By Type - United States Vasopressin Revenue, 2016-2021
4.2.2 By Type - United States Vasopressin Revenue, 2022-2027
4.2.3 By Type - United States Vasopressin Revenue Market Share, 2016-2027
4.3 By Type - United States Vasopressin Sales & Forecasts
4.3.1 By Type - United States Vasopressin Sales, 2016-2021
4.3.2 By Type - United States Vasopressin Sales, 2022-2027
4.3.3 By Type - United States Vasopressin Sales Market Share, 2016-2027
4.4 By Type - United States Vasopressin Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Vasopressin Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Pharmaceutical Manufacturing
5.1.4 Others
5.2 By Application - United States Vasopressin Revenue & Forecasts
5.2.1 By Application - United States Vasopressin Revenue, 2016-2021
5.2.2 By Application - United States Vasopressin Revenue, 2022-2027
5.2.3 By Application - United States Vasopressin Revenue Market Share, 2016-2027
5.3 By Application - United States Vasopressin Sales & Forecasts
5.3.1 By Application - United States Vasopressin Sales, 2016-2021
5.3.2 By Application - United States Vasopressin Sales, 2022-2027
5.3.3 By Application - United States Vasopressin Sales Market Share, 2016-2027
5.4 By Application - United States Vasopressin Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Endo International
6.1.1 Endo International Corporation Information
6.1.2 Endo International Overview
6.1.3 Endo International Vasopressin Sales and Revenue in United States Market (2016-2021)
6.1.4 Endo International Vasopressin Product Description
6.1.5 Endo International Recent Developments
6.2 Ferring Pharmaceuticals Corporation Information
6.2.1 Ferring Pharmaceuticals Corporation Information Corporation Information
6.2.2 Ferring Pharmaceuticals Corporation Information Overview
6.2.3 Ferring Pharmaceuticals Corporation Information Vasopressin Sales and Revenue in United States Market (2016-2021)
6.2.4 Ferring Pharmaceuticals Corporation Information Vasopressin Product Description
6.2.5 Ferring Pharmaceuticals Corporation Information Recent Developments
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Overview
6.3.3 Fresenius Kabi Vasopressin Sales and Revenue in United States Market (2016-2021)
6.3.4 Fresenius Kabi Vasopressin Product Description
6.3.5 Fresenius Kabi Recent Developments
6.4 Hybio Pharmaceutical
6.4.1 Hybio Pharmaceutical Corporation Information
6.4.2 Hybio Pharmaceutical Overview
6.4.3 Hybio Pharmaceutical Vasopressin Sales and Revenue in United States Market (2016-2021)
6.4.4 Hybio Pharmaceutical Vasopressin Product Description
6.4.5 Hybio Pharmaceutical Recent Developments
6.5 Hainan Zhonghe Pharmaceutical
6.5.1 Hainan Zhonghe Pharmaceutical Corporation Information
6.5.2 Hainan Zhonghe Pharmaceutical Overview
6.5.3 Hainan Zhonghe Pharmaceutical Vasopressin Sales and Revenue in United States Market (2016-2021)
6.5.4 Hainan Zhonghe Pharmaceutical Vasopressin Product Description
6.5.5 Hainan Zhonghe Pharmaceutical Recent Developments
6.6 Cumberland Pharmaceuticals
6.6.1 Cumberland Pharmaceuticals Corporation Information
6.6.2 Cumberland Pharmaceuticals Overview
6.6.3 Cumberland Pharmaceuticals Vasopressin Sales and Revenue in United States Market (2016-2021)
6.6.4 Cumberland Pharmaceuticals Vasopressin Product Description
6.6.5 Cumberland Pharmaceuticals Recent Developments
7 United States Vasopressin Production Capacity, Analysis
7.1 United States Vasopressin Production Capacity, 2016-2027
7.2 Vasopressin Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Vasopressin Supply Chain Analysis
9.1 Vasopressin Industry Value Chain
9.2 Vasopressin Upstream Market
9.3 Vasopressin Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Vasopressin Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Vasopressin in United States Market
Table 2. Top Vasopressin Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Vasopressin Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Vasopressin Revenue Share by Companies, 2016-2021
Table 5. United States Vasopressin Sales by Companies, (K Units), 2016-2021
Table 6. United States Vasopressin Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Vasopressin Price (2016-2021) & (US$/Unit)
Table 8. Manufacturers Vasopressin Product Type
Table 9. List of Tier 1 Vasopressin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Vasopressin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Terlipressin
Table 12. Major Manufacturers of Desmopressin
Table 13. By Type - United States Vasopressin Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Vasopressin Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Vasopressin Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Vasopressin Sales (K Units), 2016-2021
Table 17. By Type - United States Vasopressin Sales (K Units), 2022-2027
Table 18. By Application - United States Vasopressin Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Vasopressin Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Vasopressin Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Vasopressin Sales (K Units), 2016-2021
Table 22. By Application - United States Vasopressin Sales (K Units), 2022-2027
Table 23. Endo International Corporation Information
Table 24. Endo International Description and Major Businesses
Table 25. Endo International Vasopressin Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 26. Endo International Vasopressin Product
Table 27. Endo International Recent Developments
Table 28. Ferring Pharmaceuticals Corporation Information Corporation Information
Table 29. Ferring Pharmaceuticals Corporation Information Description and Major Businesses
Table 30. Ferring Pharmaceuticals Corporation Information Vasopressin Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 31. Ferring Pharmaceuticals Corporation Information Vasopressin Product
Table 32. Ferring Pharmaceuticals Corporation Information Recent Developments
Table 33. Fresenius Kabi Corporation Information
Table 34. Fresenius Kabi Description and Major Businesses
Table 35. Fresenius Kabi Vasopressin Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 36. Fresenius Kabi Vasopressin Product
Table 37. Fresenius Kabi Recent Developments
Table 38. Hybio Pharmaceutical Corporation Information
Table 39. Hybio Pharmaceutical Description and Major Businesses
Table 40. Hybio Pharmaceutical Vasopressin Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 41. Hybio Pharmaceutical Vasopressin Product
Table 42. Hybio Pharmaceutical Recent Developments
Table 43. Hainan Zhonghe Pharmaceutical Corporation Information
Table 44. Hainan Zhonghe Pharmaceutical Description and Major Businesses
Table 45. Hainan Zhonghe Pharmaceutical Vasopressin Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 46. Hainan Zhonghe Pharmaceutical Vasopressin Product
Table 47. Hainan Zhonghe Pharmaceutical Recent Developments
Table 48. Cumberland Pharmaceuticals Corporation Information
Table 49. Cumberland Pharmaceuticals Description and Major Businesses
Table 50. Cumberland Pharmaceuticals Vasopressin Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 51. Cumberland Pharmaceuticals Vasopressin Product
Table 52. Cumberland Pharmaceuticals Recent Developments
Table 53. Vasopressin Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 54. United States Vasopressin Capacity Market Share of Key Manufacturers, 2019-2021
Table 55. Vasopressin Market Opportunities & Trends in United States Market
Table 56. Vasopressin Market Drivers in United States Market
Table 57. Vasopressin Market Restraints in United States Market
Table 58. Vasopressin Raw Materials
Table 59. Vasopressin Raw Materials Suppliers in United States Market
Table 60. Typical Vasopressin Downstream
Table 61. Vasopressin Downstream Clients in United States Market
Table 62. Vasopressin Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Vasopressin Product Picture
Figure 2. Vasopressin Segment by Type
Figure 3. Vasopressin Segment by Application
Figure 4. United States Vasopressin Market Overview: 2020
Figure 5. United States Vasopressin Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Vasopressin Revenue, 2016-2027 (US$, Mn)
Figure 7. Vasopressin Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Vasopressin Revenue in 2020
Figure 9. Terlipressin Product Picture
Figure 10. Desmopressin Product Picture
Figure 11. Others Product Picture
Figure 12. By Type - United States Vasopressin Sales Market Share, 2016-2027
Figure 13. By Type - United States Vasopressin Revenue Market Share, 2016-2027
Figure 14. By Type - United States Vasopressin Price (US$/Unit), 2016-2027
Figure 15. Hospitals
Figure 16. Pharmaceutical Manufacturing
Figure 17. Others
Figure 18. By Application - United States Vasopressin Sales Market Share, 2016-2027
Figure 19. By Application - United States Vasopressin Revenue Market Share, 2016-2027
Figure 20. By Application - United States Vasopressin Price (US$/Unit), 2016-2027
Figure 21. Endo International Vasopressin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Ferring Pharmaceuticals Corporation Information Vasopressin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Fresenius Kabi Vasopressin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Hybio Pharmaceutical Vasopressin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Hainan Zhonghe Pharmaceutical Vasopressin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Cumberland Pharmaceuticals Vasopressin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. United States Vasopressin Production Capacity (K Units), 2016-2027
Figure 28. Vasopressin Industry Value Chain
Figure 29. Marketing Channels
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs